OKYO Pharma Limited
OKYO
$1.95
-$0.15-6.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 72.03% | 53.95% | 35.62% | 7.51% | -26.25% |
| Total Depreciation and Amortization | -31.58% | -30.00% | -28.57% | -15.00% | -2.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.84% | -11.20% | 196.12% | 192.74% | 185.11% |
| Change in Net Operating Assets | -39.06% | -23.54% | -13.71% | -22.46% | -32.55% |
| Cash from Operations | 80.92% | 76.81% | 73.26% | 33.19% | -22.77% |
| Capital Expenditure | -- | 60.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 60.00% | -- | -- | -- |
| Total Debt Issued | -- | -52.41% | -99.91% | -99.96% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.53% | -70.48% | -69.05% | -43.34% | -10.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.22% | -69.48% | -76.07% | -56.92% | -33.54% |
| Foreign Exchange rate Adjustments | -272.33% | -471.66% | -616.70% | -104.00% | 122.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.81% | 104.02% | -200.06% | -291.14% | -342.47% |